Predictors for Delayed Emergency Department Care in Medical Patients with Acute Infections - An International Prospective Observational Study

PLoS One. 2016 May 12;11(5):e0155363. doi: 10.1371/journal.pone.0155363. eCollection 2016.

Abstract

Introduction: In overcrowded emergency department (ED) care, short time to start effective antibiotic treatment has been evidenced to improve infection-related clinical outcomes. Our objective was to study factors associated with delays in initial ED care within an international prospective medical ED patient population presenting with acute infections.

Methods: We report data from an international prospective observational cohort study including patients with a main diagnosis of infection from three tertiary care hospitals in Switzerland, France and the United States (US). We studied predictors for delays in starting antibiotic treatment by using multivariate regression analyses.

Results: Overall, 544 medical ED patients with a main diagnosis of acute infection and antibiotic treatment were included, mainly pneumonia (n = 218; 40.1%), urinary tract (n = 141; 25.9%), and gastrointestinal infections (n = 58; 10.7%). The overall median time to start antibiotic therapy was 214 minutes (95% CI: 199, 228), with a median length of ED stay (ED LOS) of 322 minutes (95% CI: 308, 335). We found large variations of time to start antibiotic treatment depending on hospital centre and type of infection. The diagnosis of a gastrointestinal infection was the most significant predictor for delay in antibiotic treatment (+119 minutes compared to patients with pneumonia; 95% CI: 58, 181; p<0.001).

Conclusions: We found high variations in hospital ED performance in regard to start antibiotic treatment. The implementation of measures to reduce treatment times has the potential to improve patient care.

Publication types

  • Observational Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Aged
  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / therapeutic use
  • Communicable Diseases / drug therapy*
  • Emergency Medical Services*
  • Emergency Service, Hospital*
  • Female
  • Humans
  • Internationality*
  • Male
  • Prospective Studies
  • Time Factors

Substances

  • Anti-Bacterial Agents

Grants and funding

Thermofisher provided an unrestricted research grant for this study. PS is supported by the Swiss National Science Foundation (SNSF Professorship, PP00P3_150531 / 1). This study was also supported by the Schweizerische Akademie der Medizinischen Wissenschaften (SAMW). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.